$CTXR Income Statement | Understand Stock

$CTXR

$0.50 +$0.05 (11.62%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021
Operating Expenses:
Research and development
General and administrative
Stock-based compensation – general and administrative
Total Operating Expenses
Operating Loss
Other Income (Expense):
Interest income
Other income
Total Other Income, Net
Interest expense
Gain on sale of New Jersey net operating losses

Total Other Income (Expense), Net
Loss before Income Taxes
Income tax expense
Deemed dividend on warrant extension
Net Loss
Net loss attributable to non-controlling interest
Deemed dividend on warrant extension
Net Loss Applicable to Common Stockholders
Net Loss Per Share Applicable to Common Stockholders - Basic and Diluted (in Dollars per share)
Basic and diluted (in Shares)
Net Loss Per Share Applicable to Common Stockholders - Basic (in Dollars per share)
Net Loss Per Share Applicable to Common Stockholders - Diluted (in Dollars per share)
Weighted Average Common Shares Outstanding
Basic (in Shares)
Diluted (in Shares)

Comments